A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2001
10/11/2001	WO2001074376A2 Cathepsin inhibitors in cancer treatment
10/11/2001	WO2001074373A2 Hemoglobinase inhibitors and methods of use
10/11/2001	WO2001074361A1 Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract
10/11/2001	WO2001074360A1 Therapeutic combinations of antihypertensive and antiangiogenic agents
10/11/2001	WO2001074346A2 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes
10/11/2001	WO2001074317A1 Methods of modulating hair growth
10/11/2001	WO2001074298A2 Methods and compositions for regulating memory consolidation
10/11/2001	WO2001074173A1 Supplementation of equine feedstuffs
10/11/2001	WO2001074164A1 Methods of modulating hair growth
10/11/2001	WO2001074163A1 Compositions and methods of using hiv vpr
10/11/2001	WO2001074162A1 Treatment of sleep disorders with hypocretin-1
10/11/2001	WO2001074136A2 Telomerase inhibitor polynucleotides
10/11/2001	WO2001074128A2 A novel polypeptide, microtubulin 11 and the polynucleotide encoding the polypeptide
10/11/2001	WO2001066585A8 A new polypeptide-human protease regulatory protein 10 and the p olynucleotide encoding it
10/11/2001	WO2001056627A8 Medical device coated with antimicrobial peptides
10/11/2001	WO2001048190A8 Therapeutic uses of lna-modified oligonucleotides
10/11/2001	WO2001045746A3 Methods and compositions for prolonging elimination half-times of bioactive compounds
10/11/2001	WO2001044281A3 Human secretin-like g-protein coupled receptor
10/11/2001	WO2001036640A3 Human fgf-21 gene and gene expression products
10/11/2001	WO2001031003B1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response
10/11/2001	WO2001029175A3 Antisense modulation of fra-1 expression
10/11/2001	WO2001025269A3 Human g-protein coupled receptor
10/11/2001	WO2001024816A3 Compositions and methods relating to the inhibition of casomorphin and gluteomorphin
10/11/2001	WO2001024763A3 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/11/2001	WO2001023587A3 Serine protease
10/11/2001	WO2001023521A9 Polypeptide derivatives of parathyroid hormone (pth)
10/11/2001	WO2001021765A3 METHOD FOR THE SELECTIVE PROTECTION OF PROLIFERATING NORMAL CELLS AND THE SELECTIVE ERADICATION OF TUMOR CELLS HAVING AN INACTIVE p53 PATHWAY
10/11/2001	WO2001021202A3 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells
10/11/2001	WO2001020025A3 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
10/11/2001	WO2001018038A3 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis
10/11/2001	WO2001007625A3 Ehrlichia canis genes and vaccines
10/11/2001	WO2001007470A3 Human nervous system-associated proteins
10/11/2001	WO2001001627A3 Server-assisted regeneration of a strong secret from a weak secret
10/11/2001	WO2000062736A3 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/11/2001	WO2000053730A9 Medical preparations for the treatment of alpha-galactosidase a deficiency
10/11/2001	WO2000050633A9 Method for cloning signal transduction intermediates
10/11/2001	WO2000050063A8 Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
10/11/2001	WO2000029549A3 Low oxygen culturing of cells
10/11/2001	WO2000026248A3 Tuberculosis diagnostic test
10/11/2001	WO1999063066A3 Amino-modified ribozymes
10/11/2001	US20010029617 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
10/11/2001	US20010029295 Isolated polynucleotide
10/11/2001	US20010029293 Icam-related protein
10/11/2001	US20010029292 Sepsis
10/11/2001	US20010029259 Therapy for obesity, diabetes, sexual disorders
10/11/2001	US20010029251 Administering cytomegalo virus protein
10/11/2001	US20010029250 Antiinflammatory agents; anticarcinogenic agents
10/11/2001	US20010029249 Adenovirus comprising a gene coding for glutathione peroxidase
10/11/2001	US20010029246 Antiproliferative agent
10/11/2001	US20010029245 Administering a bactericide permeability inducing protein
10/11/2001	US20010029046 A deepithelialized skin diffusion cell system comprising, donor and receptor compartments, and a deepithelized skin sample when placed its deepithelialized side faces into donar compartment and dermal side faces into receptor compartment
10/11/2001	US20010029034 Hemostasis system-related disorders treatment
10/11/2001	US20010029033 Novel gene rno upregulated in leukemia cells by nitric oxide and DMSO
10/11/2001	US20010029031 Polynucleotides encoding human sodium bicarbonate cotransporters
10/11/2001	US20010029020 In vitro determination of metastatic stomach, esophageal, and colorectal cancer from sampling cells outside of the colorectal track for gene transcript or protein
10/11/2001	US20010029019 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
10/11/2001	US20010029015 For detecting mutations and polymorphisms in torsin genemedical diagnosis
10/11/2001	US20010029012 Immortalizing cells via administering protein derived from Epstein-Barr virus; purine synthesis; telomerases
10/11/2001	US20010028895 Decreasing amyloid protein
10/11/2001	US20010028889 Topical
10/11/2001	US20010028883 Papillomavirus cellular receptor
10/11/2001	US20010028882 Anti-cryptosporidium parvum preparations
10/11/2001	US20010028880 Administering protein c
10/11/2001	US20010028878 Culture product
10/11/2001	EP1144591A3 Low oxygen culturing of cells
10/11/2001	EP1144447A3 Tuberculosis diagnostic test
10/11/2001	DE10017253A1 Use of BK-RiV preparations for inducing self-producing mesenchymal organ replacements, in humans or animals, particularly for restoration and activation of the thymus
10/11/2001	DE10014007A1 Medicament for pulmonary or intranasal administration, useful for treating withdrawal symptoms, sleeping disorders or stress, comprises delta-sleep inducing peptide
10/11/2001	CA2421464A1 Combined interferon alfa and liposomal-encapsulated all-trans retinoic acid, including preparation and use
10/11/2001	CA2413211A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides
10/11/2001	CA2408904A1 Compositions and methods of using hiv vpr
10/11/2001	CA2405549A1 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcription coupled repair genes
10/11/2001	CA2405484A1 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use
10/11/2001	CA2405319A1 Methods and compositions for modulating integrin-mediated cell-cell interactions
10/11/2001	CA2405299A1 Method of treatment using ligand-immunogen conjugates
10/11/2001	CA2405043A1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
10/11/2001	CA2404965A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
10/11/2001	CA2404896A1 Human ion channel protein and polynucleotides encoding the same
10/11/2001	CA2404890A1 Rna sequence-specific mediators of rna interference
10/11/2001	CA2404869A1 Peptides mimicking the biological activity of steroid hormones and their uses
10/11/2001	CA2404572A1 Inhibition of thrombosis by treatment with p-selectin antagnosits
10/11/2001	CA2404555A1 Novel nucleic acids and polypeptides
10/11/2001	CA2404541A1 G-protein coupled receptors and nucleic acids encoding same
10/11/2001	CA2404526A1 Protein amf-1 to amf-10 and nucleic acids encoding the same
10/11/2001	CA2404519A1 Wnt-7b-like polypeptides and nucleic acids encoding same
10/11/2001	CA2404501A1 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides
10/11/2001	CA2404484A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/11/2001	CA2404479A1 Hybrid cytokine of il-7 and .beta.-chain of hepatocyte growth factor
10/11/2001	CA2404373A1 O-aryl glucoside sglt2 inhibitors and method
10/11/2001	CA2404369A1 Stable thyroid hormone preparations and method of making same
10/11/2001	CA2404365A1 Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma
10/11/2001	CA2404350A1 Control of a gene induced by oxidized lipids in human artery wall cells
10/11/2001	CA2404300A1 Medical devices suitable for gene therapy regimens
10/11/2001	CA2404257A1 Novel protein, dna thereof and process for producing the same
10/11/2001	CA2404074A1 Human polynucleotides, polypeptides, and antibodies
10/11/2001	CA2404023A1 Cyclic lactams as inhibitors of a.beta. protein production
10/11/2001	CA2403998A1 Mucin-1 specific binding members and methods of use thereof
10/11/2001	CA2403950A1 Treatment of renal disorders
10/11/2001	CA2403612A1 Improved treatment of neovascularization
10/11/2001	CA2403550A1 Cyclic lactams as inhibitors of a-.beta. protein production

1 ... 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 2198 2199 2200 2201 2202 ... 3163